Navigation Links
OncoMed Pharmaceuticals Names Dr. Jakob Dupont VP Clinical Research
Date:10/3/2011

REDWOOD CITY, Calif., Oct. 3, 2011 /PRNewswire/ -- OncoMed Pharmaceuticals, Inc., a privately-held company developing novel therapeutics that target cancer stem cells, today announced that Jakob Dupont, M.D., formerly Global Medical Director for Avastin® (bevacizumab) at Genentech, a member of the Roche Group, has joined the company as Vice President, Clinical Research. At OncoMed, Dr. Dupont will be part of a global development team advancing multiple anti-cancer stem cell therapeutics through all phases of clinical development.

At Genentech, Dr. Dupont oversaw the global medical strategy and late-stage medical program for Avastin. In that role, he led a team of international medical leaders, worked closely with the business team on brand planning, and served as an Avastin spokesperson to the global investment community.

"Dr. Dupont brings to OncoMed more than 13 years of academic and pharmaceutical drug development expertise, in particular, in the advancement of novel oncology drugs and biologics from clinical development through the approval and licensure process," said Paul Hastings, President and Chief Executive Officer of OncoMed Pharmaceuticals. "Dr. Dupont's expertise, combined with his track record with the investment community and experience with predictive biomarkers and translational medicine, provide a perspective that complements the resident skills of our leadership team. As OncoMed's cancer stem cell programs advance in clinical development, we expect Dr. Dupont will play a key role in designing and executing clinical studies, as well as effectively positioning our novel drugs in the oncology marketplace."

Dr. Dupont's successes include developing a number of key oncology drugs including: Avastin® (bevacizumab); VEGF Trap; ALIMTA® (pemetrexed for injection); VELCADE® (bortezomib); Xyotax™ (paclitaxel poliglumex); and several other new molecular oncologic en
'/>"/>

SOURCE OncoMed Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. OncoMed Chooses SynCo Bio Partners to Fill and Finish its Lead Antibody
2. SynCo Expands Agreement with OncoMed Pharmaceuticals to Manufacture Cancer Stem Cell Antibodies
3. Bayer and OncoMed Pharmaceuticals Enter Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics
4. OncoMed Pharmaceuticals Awarded Five Therapeutic Discovery Project Grants Totaling $1.2 Million
5. OncoMed Pharmaceuticals Initiates Phase 1 Clinical Trial of Anti-Cancer Stem Cell Therapeutic OMP-59R5
6. OncoMed Anti-Cancer Stem Cell Antibody OMP-21M18 Demonstrates Potent Activity in Preclinical Studies Against Human Colon Cancer Tumors Regardless of KRAS Mutation Status
7. OncoMed Pharmaceuticals Announces FDA Clearance to Commence Phase 1 Testing of Anti-Cancer Stem Cell Therapeutic OMP-18R5
8. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
9. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
10. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/14/2014)... , Sept. 14, 2014  Amgen (NASDAQ: AMGN ) ... ystolic H eart failure treatment with the ... T rial) study evaluating ivabradine in patients with chronic ... Annual Scientific Meeting of the Heart Failure Society of America ... analysis from the SHIFT study confirmed low systolic blood pressure ...
(Date:9/14/2014)... Sept. 14, 2014  Abbott announced today positive ... first prospective, randomized, controlled trial comparing the safety ... to Abbott,s market-leading metallic XIENCE family of DES.  ... , included 501 people with coronary artery ... disease. The results were featured at a late-breaking ...
(Date:9/13/2014)... , Sept. 13, 2014  Edwards Lifesciences ... leader in the science of heart valves and ... clinical outcomes for inoperable patients treated in The ... for transcatheter aortic valve replacement (TAVR) in patients ... were presented as part of the late-breaking clinical ...
Breaking Medicine Technology:Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 2Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 3Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 4Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 5Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 6Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 7Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 8Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure 9ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent 2ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent 3ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent 4ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent 5Significant Patient Benefits With Edwards Sapien Valve Demonstrated In 5-Year Partner Trial Data 2
... Sanmina-SCI Corporation (Nasdaq: SANM ), a ... world,s most complex and valuable electronic and mechanical ... has been awarded ISO 13485 certification for medical ... manufacturing capabilities, and the company,s focus on meeting ...
... Sept. 8, 2011 Marshall Edwards, Inc. (Nasdaq: ... clinical development of novel therapeutics targeting cancer metabolism, announced ... of the Company,s lead drug candidate ME-143 in patients ... in collaboration with the Sarah Cannon Research Institute in ...
Cached Medicine Technology:Sanmina-SCI Kenosha, Wisconsin Facility Awarded ISO 13485 Certification for Medical Devices 2Sanmina-SCI Kenosha, Wisconsin Facility Awarded ISO 13485 Certification for Medical Devices 3Marshall Edwards Announces Initiation of Phase I Clinical Trial of Lead Oncology Drug Candidate ME-143 2Marshall Edwards Announces Initiation of Phase I Clinical Trial of Lead Oncology Drug Candidate ME-143 3
(Date:9/14/2014)... UWDress.com, is an internationally well-known designer and ... its new range of cocktail dresses under $100 ... to worldwide ladies, the company is also providing big ... blue evening gowns, black formal gowns and so on. ... , The company’s senior spokesman says, “We are ...
(Date:9/13/2014)... 13, 2014 Ticket Down is ... tickets. This beloved pop-rock group that originally formed in 1994 ... album. Fans of the group had been anticipating a new ... fans were excited yet about the release of their new ... has announced a massive worldwide tour beginning in the United ...
(Date:9/13/2014)... Termlifeinsurancequotesonline.org has released a new ... for smokers. , Smokers can now find affordable ... examination. The only application process clients have to go ... few medical questions. , Since smoking will increase ... making a decision. Comparing life insurance policies is now ...
(Date:9/13/2014)... September 13, 2014 Bedros Keuilian, founder of ... fitness marketing coach , has always been an advocate of ... most useful days are over, but the post explains that ... need to change. , “A lot of people think of ... says Keuilian. “They run a special and the only thing ...
(Date:9/13/2014)... (PRWEB) September 13, 2014 Gainesville ... the community to their official Grand Opening celebration today, ... part of the international Fit Body Boot Camp franchise, ... workouts designed to get busy people the fast results ... , “Our workouts are hard work, but we make ...
Breaking Medicine News(10 mins):Health News:UWDress.com: Elegant Cocktail Dresses Under $100 Now Offered 2Health News:Maroon 5 Tickets Now on Sale in Philadelphia, Washington DC, Nashville, San Jose, Chicago, Dallas, Los Angeles, Tacoma, Saint Paul, Vancouver, San Diego & New York 2Health News:Maroon 5 Tickets Now on Sale in Philadelphia, Washington DC, Nashville, San Jose, Chicago, Dallas, Los Angeles, Tacoma, Saint Paul, Vancouver, San Diego & New York 3Health News:Smokers Can Qualify for Life Insurance Without Taking a Medical Exam 2Health News:Renegade Fitness Marketing Expert Reveals How Personal Trainers Can Use Groupon More Effectively to Sign New Clients 2Health News:Renegade Fitness Marketing Expert Reveals How Personal Trainers Can Use Groupon More Effectively to Sign New Clients 3Health News:Gainesville Fit Body Boot Camp Announces Grand Opening of New Fitness Boot Camp 2Health News:Gainesville Fit Body Boot Camp Announces Grand Opening of New Fitness Boot Camp 3
... Reporter , THURSDAY, June 23 (HealthDay News) -- After suffering ... hopes and fears about the future are less depressed and ... In fact, 48 percent of the people who participated ... stroke were not depressed a year later, compared to 37.7 ...
... stress appears to enhance the lung-damaging effects of traffic-related ... the Keck School of Medicine of the University of ... will appear online ahead of the print edition of ... and Critical Care Medicine . "This is the ...
... team led by Johns Hopkins researchers has found that a ... with abnormally dense blood vessel growth in the skin lining ... of Familial Cancer , could lead to a quick ... DNA tests and colonoscopies, and sometimes goes unnoticed until cancer ...
... News) -- Among heart attack patients, black Americans generally ... restore blood flow to their hearts, according to a ... hospital quality, not the race of individual patients, the ... attack patients who arrive at hospitals that aren,t equipped ...
... media use, encouraging infants and young children in preschool ... active play, and requiring child care providers to promote ... to curb high rates of obesity among America,s youngest ... Medicine. The report recommends steps that ...
... the Georgia Tech Research Institute (GTRI) have developed a ... disease and certain other neurological conditions to use the ... tremors and relay the results to medical personnel. ... replace subjective tests now used to assess the severity ...
Cached Medicine News:Health News:Early Talk Therapy May Help Stroke Patients Bounce Back 2Health News:Early Talk Therapy May Help Stroke Patients Bounce Back 3Health News:Exposure to parental stress increases pollution-related lung damage in children 2Health News:Hereditary colon cancer syndrome marked by abnormally dense blood vessel growth in mouth 2Health News:Hereditary colon cancer syndrome marked by abnormally dense blood vessel growth in mouth 3Health News:Hospital Delays Tied to Racial Divide in Heart Attack Care 2Health News:Policies that promote healthy eating, activity and sleep are needed to curb obesity in infants, toddlers and preschoolers 2Health News:Policies that promote healthy eating, activity and sleep are needed to curb obesity in infants, toddlers and preschoolers 3Health News:Policies that promote healthy eating, activity and sleep are needed to curb obesity in infants, toddlers and preschoolers 4Health News:New application for iPhone may support monitoring and research on Parkinson's disease 2Health News:New application for iPhone may support monitoring and research on Parkinson's disease 3
Flattened 13 mm "Graefe type" hook, with 1.5 mm oval hole. Flat serrated handle with polished finish. Overall length: 5.6 inches....
Fine short working end. Overall length: 4.9 inches. Most popular size or model....
Designed for manipulating one piece lenses. The "Y: hook is excellent for capturing haptics and centering the lens. Straight shaft with "Y" shaped tip. Round knurled handle with dull finish. Overall ...
0.3 mm hook angled 45 degrees, 9 mm from tip to bend. Flat smooth handle with polished finish. Overall length: 4.6 inches....
Medicine Products: